Benitec Biopharma Inc.BNTCNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+17.6%
5Y CAGR+43.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+17.6%/yr
vs +22.2%/yr prior
5Y CAGR
+43.6%/yr
Recent deceleration
Acceleration
-4.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.1x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $18.33M | +17.4% |
| 2024 | $15.61M | +22.2% |
| 2023 | $12.77M | +13.3% |
| 2022 | $11.27M | +60.6% |
| 2021 | $7.02M | +133.9% |
| 2020 | $3.00M | +38.0% |
| 2019 | $2.17M | -57.0% |
| 2018 | $5.06M | -4.9% |
| 2017 | $5.32M | -46.4% |
| 2016 | $9.92M | - |